Xiamen-Borstel Joint Laboratory of Autoimmunity, The Medical College of Xiamen University, Xiamen, China.
Institute of Psychiatry and Neuroscience, Xinxiang Medical University, Xinxiang, China.
Front Immunol. 2018 Oct 31;9:2362. doi: 10.3389/fimmu.2018.02362. eCollection 2018.
Ectopic expression of MHC II molecules on glandular cells is a feature of primary Sjögren's syndrome (pSS). However, the cause of this ectopic expression and its potential role in the pathogenesis of the disease remains elusive. Here, we report that ectopic expression of MHC II molecules on glandular cells represents an early presymptomatic event in a mouse model of pSS induced by immunization of Ro60_316-335 peptide emulsified in TiterMax® as an adjuvant. Ectopic expression of MHC II was induced by TiterMax® but not by complete freund's adjuvant (CFA). Furthermore, immunization with Ro60_316-335 peptide emulsified in TiterMax®, but not in CFA, induced a pSS-like disease in mice. Our results suggests that ectopic expression of MHC II molecules on glandular cells represents a presymptomatic feature of pSS and that such ectopic expression can be induced by exogenous factors. In addition, this study also provides a novel mechanism how adjuvants can amplify immune responses.
MHC II 分子在腺细胞上的异位表达是原发性干燥综合征(pSS)的一个特征。然而,这种异位表达的原因及其在疾病发病机制中的潜在作用仍不清楚。在这里,我们报告了在 Ro60_316-335 肽乳化在 TiterMax®佐剂中的免疫诱导的 pSS 小鼠模型中,腺细胞上 MHC II 分子的异位表达代表了一个早期的无症状前事件。TiterMax®诱导了 MHC II 的异位表达,但完全弗氏佐剂(CFA)没有。此外,用 Ro60_316-335 肽乳化在 TiterMax®中免疫,而不是在 CFA 中免疫,可诱导小鼠发生 pSS 样疾病。我们的结果表明,MHC II 分子在腺细胞上的异位表达代表了 pSS 的无症状前特征,并且这种异位表达可以被外源性因素诱导。此外,这项研究还提供了一种新的机制,说明佐剂如何增强免疫反应。